10009-20-8,
H-Lys(Tfa)-OH,
N-6-Trifluoroacetyl-L-lysine,
N6-(Trifluoroacetyl)-L-lysine,
N6-Trifluoroacetyl-L-lysine,
N6-Trifluoroaccety-L-lysine,
epsilon-TFA-lysine,
Nepsilon-Trifluoroacetyl-L-lysine,
L-Lysine, N6-(trifluoroacetyl)-,
N(6)-trifluoroacetyl-L-lysine,
CHEBI:61064,
N(6)-(trifluoroacetyl)-L-lysine,
N(epsilon)-trifluoroacetyl-L-lysine,
(S)-2-Amino-6-(2,2,2-trifluoroacetamido)hexanoic acid,
J-502413,
(2S)-2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid,
(2S)-2-amino-6-(2,2,2-trifluoroacetylamino)hexanoic acid,
MFCD00037223,
C8H13F3N2O3,
AK-41363,
Lysine, N6-(trifluoroacetyl)-, L-,
H-L-Lys(Tfa)-OH,
Epitope ID:150923,
SCHEMBL875166,
N-|A-Trifluoroacetyl-L-lysine,
Jsp000057,
CTK3J5148,
DTXSID70142926,
N~6~-(trifluoroacetyl)-L-lysine,
PZZHRSVBHRVIMI-YFKPBYRVSA-N,
Nepsilon -trifluoroacetyl-L-lysine,
ACT07152,
EBD47106,
KS-00000FB3,
ZINC2384794,
ZX-AP012231,
ANW-14156,
PC1591,
SBB058284,
AKOS015920404,
AKOS015924094,
AAA0001523,
AC-6228,
AM81963,
FCH3661839,
RP17572,
(S)-2-Amino-6-pivalamidohexanoic acid,
N6-(2,2,2-trifluoroacetyl)-L-lysine,
AJ-35123,
AN-10221,
AS-12921,
BC677967,
BR-41363,
CC-32256,
SC-09733,
L-Lysine, N6-(2,2,2-trifluoroacetyl)-,
AB0004499,
AX8010712,
RT-002364,
FT-0080237,
FT-0636611,
ST24030746,
ST51016163,
N6-Trifluoroacetyl-L-lysine (for lisinopril),
M-1703,
(S)-6-trifluoroacetylamino-2-aminohexanoic acid,
(2S)-2-amino-6-(trifluoroacetamido)hexanoic acid,
009H208,
C-14566,
Nepsilon-Trifluoroacetyl-L-lysine, >=96.0% (TLC),
Potassium 3,6-dichloro-2-methoxybenzoate; Potassium 3,6-dichloro-o-anisate,
C8-H13-F3-N2-O3,
CID7009573,
A7236,
T2815,
Nepsilon-Trifluoroacetyl-L-lysine, 98% - 25G 25g,
2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoic Acid,
(S)-6-(Trifluoroacetylamino)-2-aminohexanoic acid; N6-(Trifluoroacetyl)-L-lysine; N6-(Trifluoroacetyl)lysine;,